52
Participants
Start Date
March 31, 2007
Primary Completion Date
December 31, 2015
Study Completion Date
August 31, 2016
CAN-2409
Single dose of 3x10e11 vector particles of CAN-2409 delivered to the tumor bed after resection on day 0.
Valacyclovir
Single course of valacyclovir at dose of 2 grams orally three times per day for 14 days starting on day 1-3
Temozolomide
Concomitant TMZ will be administered orally once a day at a dose of 75 mg/m2 starting the next day after completing prodrug and continued for 6 weeks. Adjuvant TMZ will be administered days 1 to 5 of a 28-day cycle for 6 cycles with 150 mg/m2 administered for cycle 1, and 150 to 200 mg/m2 administered for cycles 2 to 6. Adjuvant treatment will start 1 month following completing RT.
Radiation therapy
Radiation will be administered to up-front patients as per standard of care for the patient. It will start 3-7 days after CAN-2409 injection, preferably closer to 3 days. It will consist of standard external field radiation, limited to the area of tumor and brain adjacent to tumor, fractionated at doses of 200cGy per day for approximately 6 weeks to a total of 5500-6000 cGy.
The Ohio State University Medical Center, Dept. Neurological Surgery, Columbus
The University of Chicago, Chicago
The Methodist Hospital Neurological Institute, Houston
City of Hope Medical Center, Duarte
Lead Sponsor
Candel Therapeutics, Inc.
INDUSTRY